Vaccinexincis A Clinical Stage Biotechnology Company Based In Rochesternew Yorkfounded In 1997 From Research At The University Of Rochesterthe Company Is Dedicated To Developing Innovative Therapies For Cancer And Neurologic Diseasesits Primary Focus Is On Inhibiting Semaphorin 4Dsema4D A Biological Factor Involved In Immune Suppression And Neuroinflammation The Company Utilizes Its Proprietary Drug Discovery Platformactivmaba To Create New Treatment Opportunitiesits Lead Drug Candidatepepinemabis Designed To Block Sema4Dpotentially Enhancing Immune Responses Against Tumors And Addressing Chronic Neurological Disorders Like Alzheimerae S And Huntingtonae S Diseasevaccinex Aims To Improve Global Health Through Technology And Partnershipswhile Also Expanding Its Presence In The Biotechnology Fieldthe Company Is Publicly Traded On The Nasdaq Under The Ticker Symbol Vcnx And Has A Dedicated Team Of Approximately 40 Employees
No conferences found for this company.
| Company Name | Vaccinex Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
